UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Thoracic impedance pneumography in propofol-sedated patients undergoing percutaneous endoscopic gastrostomy (PEG) placement in gastrointestinal endoscopy: A prospective, randomized trial

Journal of clinical anesthesia, 2024-06, Vol.94, p.111403-111403, Article 111403

2024

Link zum Volltext

Verfügbarkeit prüfen

Review article: predicting response in hepatitis C virus therapy

Alimentary pharmacology & therapeutics, 2006-04, Vol.23 (8), p.1043-1054

2006

Link zum Volltext

Verfügbarkeit prüfen

1364 DEEP SEQUENCING REVEALS ACCUMULATION OF VIRAL VARIANTS IN HCV GENOTYPE 1 INFECTED PATIENTS DURING RIBAVIRIN MONOTHERAPY

Journal of hepatology, 2011-03, Vol.54, p.S540-S541

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C viral dynamics during ribavirin priming differ according to prior treatment response and HCV type

Journal of viral hepatitis, 2016-11, Vol.23 (11), p.866-872

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection

Journal of viral hepatitis, 2014-01, Vol.21 (1), p.42-52

2014

Link zum Volltext

Verfügbarkeit prüfen

Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy

Journal of viral hepatitis, 2008-11, Vol.15 (11), p.790-796

2008

Link zum Volltext

Verfügbarkeit prüfen

799 EFFECTS OF RIBAVIRIN ON NK CELL PHENOTYPE AND FUNCTION IN HEPATITIS C VIRUS INFECTION

Journal of hepatology, 2012-04, Vol.56, p.S312-S313

2012

Link zum Volltext

Verfügbarkeit prüfen

1105 BASELINE CHARACTERISTICS CAN HELP TO PREDICT HEPATIC DECOMPENSATION DURING ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND ADVANCED LIVER CIRRHOSIS

Journal of hepatology, 2012-04, Vol.56, p.S435-S435

2012

Link zum Volltext

Verfügbarkeit prüfen

455 HCV VIRAL KINETICS DURING RIBAVIRIN MONOTHERAPY: RESULTS OF A RANDOMIZED PARTIALLY DOUBLE BLIND PLACEBO CONTROLLED CLINICAL TRIAL

Journal of hepatology, 2011-03, Vol.54, p.S185-S185

2011

Link zum Volltext

Verfügbarkeit prüfen

Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C

Journal of viral hepatitis, 2005-05, Vol.12 (3), p.307-314

2005

Link zum Volltext

Verfügbarkeit prüfen

754 IMPACT OF RIBAVIRIN ON SUBGENOMIC HEPATITIS C VIRUS RNA DECAY DURING TREATMENT WITH INTERFERON ALFA AND THE PROTEASE INHIBITOR TELAPREVIR

Journal of hepatology, 2010, Vol.52, p.S293-S294

2010

Link zum Volltext

Verfügbarkeit prüfen

Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C

Journal of hepatology, 2004-05, Vol.40 (5), p.845-852

2004

Link zum Volltext

Verfügbarkeit prüfen

259 ANTIVIRAL EFFICACY OF RIBAVIRIN MONOTHERAPY FOLLOWED BY STANDARD COMBINATION TREATMENT IN CHRONIC HEPATITIS C

Journal of hepatology, 2010, Vol.52, p.S109-S109

2010

Link zum Volltext

Verfügbarkeit prüfen

616 EFFECT OF RIBAVIRIN ON THE FREQUENCY OF RNASE L CLEAVAGE SITES WITHIN THE HEPATITIS C VIRAL GENOME

Journal of hepatology, 2009, Vol.50, p.S226-S227

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genome

Journal of viral hepatitis, 2010-03, Vol.17 (3), p.217-221

2010

Link zum Volltext

Verfügbarkeit prüfen

Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases

Journal of viral hepatitis, 2007-07, Vol.14 (7), p.484-491

2007

Link zum Volltext

Verfügbarkeit prüfen

738 BONE MINERAL DENSITY AND METABOLISM IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS C

Journal of hepatology, 2008, Vol.48, p.S275-S276

2008

Link zum Volltext

Verfügbarkeit prüfen

[430] RIBAVIRIN ACTS AS HEPATITIS C VIRUS MUTAGEN ON NONSTRUCTURAL 5B QUASISPECIES IN VITRO AND DURING ANTIVIRAL THERAPY

Journal of hepatology, 2007, Vol.46, p.S164-S164

2007

Link zum Volltext

Verfügbarkeit prüfen

[521] MULTIFACTORIAL ANALYSIS OF HOST AND VIRUS RELATED RISK FACTORS FOR THE DEVELOPMENT OF VIRAL RESISTANCE DURING LONG-TERM LAMIVUDINE TREATMENT OF HBV INFECTION OVER UP TO NINE YEARS

Journal of hepatology, 2007, Vol.46, p.S198-S198

2007

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.729-737

2006

Link zum Volltext

Verfügbarkeit prüfen

Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment-results of a pilot study

Metabolic brain disease, 2002-06, Vol.17 (2), p.103-111

2002

Link zum Volltext

Verfügbarkeit prüfen

Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B

Zeitschrift für Gastroenterologie, 2003-03, Vol.41 (3), p.249

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical Significance of In Vitro Replication–Enhancing Mutations of the Hepatitis C Virus (HCV) Replicon in Patients with Chronic HCV Infection

The Journal of infectious diseases, 2005-11, Vol.192 (10), p.1710-1719

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(78)

Sprache

Englisch
(62)
Deutsch
(16)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thoracic impedance pneumography in propofol-sedated patients undergoing percutaneous endoscopic gastrostomy (PEG) placement in gastrointestinal endoscopy: A prospective, randomized trial

Review article: predicting response in hepatitis C virus therapy

1364 DEEP SEQUENCING REVEALS ACCUMULATION OF VIRAL VARIANTS IN HCV GENOTYPE 1 INFECTED PATIENTS DURING RIBAVIRIN MONOTHERAPY

Hepatitis C viral dynamics during ribavirin priming differ according to prior treatment response and HCV type

Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection

Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy

799 EFFECTS OF RIBAVIRIN ON NK CELL PHENOTYPE AND FUNCTION IN HEPATITIS C VIRUS INFECTION

1105 BASELINE CHARACTERISTICS CAN HELP TO PREDICT HEPATIC DECOMPENSATION DURING ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND ADVANCED LIVER CIRRHOSIS

455 HCV VIRAL KINETICS DURING RIBAVIRIN MONOTHERAPY: RESULTS OF A RANDOMIZED PARTIALLY DOUBLE BLIND PLACEBO CONTROLLED CLINICAL TRIAL

Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C

754 IMPACT OF RIBAVIRIN ON SUBGENOMIC HEPATITIS C VIRUS RNA DECAY DURING TREATMENT WITH INTERFERON ALFA AND THE PROTEASE INHIBITOR TELAPREVIR

Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C

259 ANTIVIRAL EFFICACY OF RIBAVIRIN MONOTHERAPY FOLLOWED BY STANDARD COMBINATION TREATMENT IN CHRONIC HEPATITIS C

616 EFFECT OF RIBAVIRIN ON THE FREQUENCY OF RNASE L CLEAVAGE SITES WITHIN THE HEPATITIS C VIRAL GENOME

Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genome

Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases

738 BONE MINERAL DENSITY AND METABOLISM IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS C

[430] RIBAVIRIN ACTS AS HEPATITIS C VIRUS MUTAGEN ON NONSTRUCTURAL 5B QUASISPECIES IN VITRO AND DURING ANTIVIRAL THERAPY

[521] MULTIFACTORIAL ANALYSIS OF HOST AND VIRUS RELATED RISK FACTORS FOR THE DEVELOPMENT OF VIRAL RESISTANCE DURING LONG-TERM LAMIVUDINE TREATMENT OF HBV INFECTION OVER UP TO NINE YEARS

Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5

Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment-results of a pilot study

Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B

Clinical Significance of In Vitro Replication–Enhancing Mutations of the Hepatitis C Virus (HCV) Replicon in Patients with Chronic HCV Infection

Suchergebnisse filtern